The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noun, G.
Right arrow Articles by Pla, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noun, G.
Right arrow Articles by Pla, M.
The Journal of Immunology, 1998, 161: 148-153.
Copyright © 1998 by The American Association of Immunologists

Strong Alloantigenicity of the {alpha}-Helices Residues of the MHC Class I Molecule1

Ghada Noun*, Murielle Reboul*, Jean-Pierre Abastado{dagger}, Philippe Kourilsky{dagger}, François Sigaux* and Marika Pla2,*

* Mouse Immunogenetics, U462, Institut National de la Santé et de la Recherche Médicale, Institute of Hematology, Paris, France; and {dagger} U277, Institut National de la Santé et de la Recherche Médicale, Pasteur Institute, Paris, France

To evaluate the role of single residues of a MHC class I molecule in the induction of a primary allogeneic response, we have tested the ability of various point mutants (of the {alpha}-helices or ß-sheet of the {alpha}1 and {alpha}2 domains) of the Kd molecule to induce a primary cytotoxic T cell response in mice carrying the wild-type molecule. For that, we have used an in vivo model in which cells expressing mutant molecules were injected into the hind footpads of mice carrying wild-type Kd, and the recipient graft-draining popliteal lymph nodes were tested for the presence of alloreactive CTL. Under these experimental conditions, only 7 of the 25 mutant Kd molecules induced a primary allogeneic response. All of these mutations (positions 62, 65, 69, 72, 155, 163, 166) concern residues of the {alpha}-helices, demonstrating that very small variances from self in a class I molecule, located outside the peptide-binding groove, can be antigenic. To determine the peptide requirements for the generation of a primary allogeneic response, we have analyzed the repertoire of peptides selected by individual mutant molecules shown to be able or unable to induce a CTL response. No correlation was observed between the peptidic make-up presented by a given mutant and its capacity to induce a primary allogeneic response. On the whole, our data point to the alloantigenicity of potentially TCR-contacting surface residues of the MHC class I molecules.




This article has been cited by other articles:


Home page
Int ImmunolHome page
A. Moris, D. Wernet, S. Stevanovic, and H.-G. Rammensee
The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205-anti-HLA-A*0201 pairings
Int. Immunol., July 1, 2001; 13(7): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Cambiaggi, S. Darche, S. Guia, P. Kourilsky, J.-P. Abastado, and E. Vivier
Modulation of T-Cell Functions in KIR2DL3 (CD158b) Transgenic Mice
Blood, October 1, 1999; 94(7): 2396 - 2402.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. C. Hornell, J. C. Solheim, N. B. Myers, W. E. Gillanders, G. K. Balendiran, T. H. Hansen, and J. M. Connolly
Alloreactive and Syngeneic CTL Are Comparably Dependent on Interaction with MHC Class I {alpha}-Helical Residues
J. Immunol., September 15, 1999; 163(6): 3217 - 3225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Pacasova, S. Martinozzi, H.-J. Boulouis, M. Ulbrecht, J.-C. Vieville, F. Sigaux, E. H. Weiss, and M. Pla
Cell-Surface Expression and Alloantigenic Function of a Human Nonclassical Class I Molecule (HLA-E) in Transgenic Mice
J. Immunol., May 1, 1999; 162(9): 5190 - 5196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.